Stroke Prevention in Atrial Fibrillation The Role of Oral Anticoagulation

被引：12
|
作者：
Mtwesi, Viwe [1 ]
Amit, Guy [1 ]
机构：
[1] McMaster Univ, Hamilton Gen Hosp, Dept Med, Div Cardiol, 237 Barton St East, Hamilton, ON L8L 2X2, Canada
来源：
MEDICAL CLINICS OF NORTH AMERICA | 2019年 / 103卷 / 05期
关键词：
Atrial fibrillation; Stroke prevention; Anticoagulation; NOAC; Warfarin; DIRECT-CURRENT CARDIOVERSION; PREDICTING STROKE; ISCHEMIC-STROKE; ELECTRICAL CARDIOVERSION; RISK STRATIFICATION; TREATED PATIENTS; DIRECT THROMBIN; LOW-INTENSITY; PLUS ASPIRIN; WARFARIN;
D O I：
10.1016/j.mcna.2019.05.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Oral anticoagulation significantly reduces the risk of stroke in patients with atrial fibrillation (AF), and the decision to initiate therapy is based on assessing the patient's yearly risk of stroke. Although warfarin remains the drug of choice in patients with AF and artificial mechanical valves, the novel anticoagulation agents are becoming the drug of choice for all other patients with AF, because of their efficacy, safety, and ease of use. This article summarizes the current evidence for stroke prevention in AF, including valvular AF, subclinical AF, AF in patients with renal insufficiency, as well as stroke prevention around AF cardioversion.
引用
收藏
页码：847 / +
页数：17
相关论文
共 50 条
  • [11] Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation
    Waldo, Albert L.
    CARDIOLOGY CLINICS, 2009, 27 (01) : 125 - +
  • [12] Anticoagulation: Stroke prevention in patients with atrial fibrillation
    Waldo, Albert L.
    MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 (01) : 143 - +
  • [13] Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation
    Hernandez, Inmaculada
    Saba, Samir
    Zhang, Yuting
    STROKE, 2017, 48 (08) : 2289 - 2291
  • [14] Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
    Fernandez, Maria M.
    von Scheele, Birgitta
    Hogue, Susan
    Kwong, Winghan Jacqueline
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (02) : 87 - 102
  • [15] Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
    Maria M. Fernandez
    Birgitta von Schéele
    Susan Hogue
    Winghan Jacqueline Kwong
    American Journal of Cardiovascular Drugs, 2013, 13 : 87 - 102
  • [16] Understanding anticoagulation therapy for stroke prevention and atrial fibrillation
    Schellack, Natalie
    Esterhuizen, Heleen
    Schellack, Gustav
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (04) : 11 - 18
  • [17] Understanding anticoagulation therapy for stroke prevention and atrial fibrillation
    Schellack, Natalie
    Esterhuizen, Heleen
    Schellack, Gustav
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (07) : 13 - 19
  • [18] Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
    Lip, Gregory Y. H.
    Watson, Timothy
    Shantsila, Eduard
    EUROPEAN HEART JOURNAL, 2006, 27 (16) : 1893 - 1894
  • [19] Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
    Lotufo, Paulo Andrade
    SAO PAULO MEDICAL JOURNAL, 2018, 136 (04): : 273 - 275
  • [20] Use and Underuse of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Old and New Paradigms
    Pisters, Ron
    de Vos, Cees B.
    Nieuwlaat, Robby
    Crijns, Harry J. G. M.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (06): : 554 - 559
12345